These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9569417)
1. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases. McFadyen IR; Martlew VJ; Howard HL; Clarke CA BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417 [No Abstract] [Full Text] [Related]
2. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives. Everett C; Wray J BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419 [No Abstract] [Full Text] [Related]
3. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease. Craig JS; McClure BG; Tubman TR BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034 [No Abstract] [Full Text] [Related]
4. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin? Hannafin B; Lovecchio F; Blackburn P Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810 [TBL] [Abstract][Full Text] [Related]
5. Preventing RhD haemolytic disease of the newborn. Women should be counselled about source of anti-D immunoglobulin. Saha A BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569418 [No Abstract] [Full Text] [Related]
6. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997. Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199 [No Abstract] [Full Text] [Related]
7. Haemolytic disease of the newborn: the new NICE guidelines. Thompson J J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064 [TBL] [Abstract][Full Text] [Related]
8. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia]. Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356 [No Abstract] [Full Text] [Related]
14. Anti-D administration in early pregnancy--time for a new protocol. Carmody F Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328 [No Abstract] [Full Text] [Related]
15. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin. Daniels G; Finning K; Martin P; Summers J Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463 [TBL] [Abstract][Full Text] [Related]
16. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis. Lee D BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614 [No Abstract] [Full Text] [Related]
18. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?]. Benachi A; Nisand I J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919 [No Abstract] [Full Text] [Related]
19. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy]. Larsen JF; Bock JE; Jørgensen JR Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303 [No Abstract] [Full Text] [Related]
20. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable]. Sainio S; Kuosmanen M Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]